Caplight Directory>Companies>Deciduous Therapeutics-preview>Deciduoustx


Deciduous Therapeutics

Deciduous Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.deciduoustx.com/

Last Round

Grant

Oct 21, 2021

Total Funding Raised

$5.85M

Company Overview

Deciduous Therapeutics is a biotechnology company developing novel medicines that activate the endogenous immune mechanism responsible for the elimination of senescent cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

senescent cell clearancesenolyticsiNKT cell activationimmunomodulatory therapycellular senescencezombie cellslongevity biotechage-related disease therapysmall molecule therapydrug discovery platformfibrotic disease therapymetabolic disease therapyimmune surveillance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deciduous Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deciduous Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 21, 2021
SeedJul 10, 2019
View all Funding Rounds

Deciduous Therapeutics Investors

Notable investors and investment history

InvestorRounds
Bakar LabsGrant
age1Seed
Eisai InnovationGrant
Presight CapitalSeed
MBC BioLabsGrant
CRVSeed
8VCSeed
View all Investors

Deciduous Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deciduous Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deciduous Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range13
Year Founded2018
Last FundingOct 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.